Morbidity and mortality of nonagenarians undergoing CoreValve implantation
Morbidity and mortality of nonagenarians undergoing CoreValve implantation
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Nonagenarians are mostly denied from different therapeutic strategies due to high comorbidity index and risk-benefit calculation. We present the results of nonagenarians with high comorbidity index not eligible for conventional aortic valve surgery undergoing transcatheter aortic valve implantation (TAVI) with the CoreValve system.
Our retrospec...
Alternative Titles
Full title
Morbidity and mortality of nonagenarians undergoing CoreValve implantation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c438fa7ff6214256a78103c86bae6dd5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c438fa7ff6214256a78103c86bae6dd5
Other Identifiers
ISSN
1471-2261
E-ISSN
1471-2261
DOI
10.1186/1471-2261-12-80